Loading clinical trials...
Loading clinical trials...
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Conditions
Interventions
LY3526318
Placebo
Locations
37
United States
Synexus Clinical Research US, Inc.
Chandler, Arizona, United States
Synexus Clinical Research - Glendale
Glendale, Arizona, United States
Arizona Research Center
Phoenix, Arizona, United States
Alliance for Multispecialty Research, LLC Tempe
Tempe, Arizona, United States
Artemis Institute for Clinical Research
Riverside, California, United States
Artemis Institute for Clinical Research
San Diego, California, United States
Start Date
January 26, 2022
Primary Completion Date
October 13, 2022
Completion Date
October 13, 2022
Last Updated
November 22, 2023
NCT07285018
NCT06221241
NCT07377721
NCT06614322
NCT06122012
NCT04688671
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions